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Abstract
Point mutants of α1-antitrypsin form ordered polymers that are retained as inclusions within the
endoplasmic reticulum (ER) of hepatocytes in association with neonatal hepatitis, cirrhosis and
hepatocellular carcinoma. These inclusions cause cell damage and predispose to ER stress in the
absence of the classical unfolded protein response (UPR). The pathophysiology underlying this
ER stress was explored by generating cell models that conditionally express wildtype α1-
antitrypsin, two mutants that cause polymer-mediated inclusions and liver disease (E342K [the Z
allele] and H334D) and a truncated mutant (Null Hong Kong, NHK) that induces classical ER
stress and is removed by ER associated degradation. Expression of the polymeric mutants resulted
in gross changes in the ER luminal environment that recapitulated the changes seen in liver
sections from individuals with PI*ZZ α1-antitrypsin deficiency. In contrast expression of NHK
α1-antitrypsin caused electron lucent dilatation and expansion of the ER throughout the cell.
Photobleaching microscopy in live cells demonstrated a decrease in the mobility of soluble
luminal proteins in cells that express E342K and H334D α1-antitrypsin when compared to those
that express wildtype and NHK α1-antitrypsin (0.34±0.05, 0.22±0.03, 2.83±0.30 and 2.84±0.55
μm2/s respectively). There was no effect on protein mobility within ER membranes indicating that
cisternal connectivity was not disrupted. Polymer expression alone was insufficient to induce the
UPR but the resulting protein overload rendered cells hypersensitive to ER stress induced by
either tunicamycin or glucose depletion.
Conclusion—Changes in protein diffusion provide an explanation for the cellular consequences
of ER protein overload in mutants that cause inclusion body formation and α1-antitrypsin
deficiency.
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Introduction
Alpha1-antitrypsin deficiency results from point mutations that lead to the formation of
large, ordered polymers that accumulate within the ER of hepatocytes1. The resulting
inclusions cause a toxic-gain-of-function that is associated with neonatal hepatitis, cirrhosis
and hepatocellular carcinoma2. This is best exemplified by the Z (E342K), King’s (H334D),
Siiyama (S53F) and Mmalton (Δ52F) alleles3–6. Plasma eficiency of α1-antitrypsin
deficiency can also result from truncating mutations such as the Null Hong Kong (NHK)
allele that target the protein for ER-associated degradation (ERAD)7. This reduces secretion
of α1-antitrypsin but does not cause the gain-of-function liver disease. In both cases the lack
of circulating α1-antitrypsin predisposes the homozygote to early onset emphysema8.
A wide range of signalling pathways are activated to restore the ER homeostasis in response
to an overload of misfolded proteins. An important stress response is the Unfolded Protein
Response (UPR) that combines transient attenuation of protein translation with enhancement
of the ER’s protein-folding capacity, thus preventing uncontrolled aggregation of proteins
within its lumen9. This conserved stress response is tightly regulated by the activation of
three ER stress sensors operating in parallel: IRE1, PERK, and ATF6. Under non-stressed
conditions, each sensor is held in an inactive state by binding of the ER chaperone BiP to its
luminal domain. When misfolded protein levels increase during ER stress, the UPR is
activated, at least in part, through the titration of BiP away from these sensor molecules.
We aimed to determine the impact of polymers and truncated α1-antitrypsin on the ER
environment. We show that the accumulation of ordered polymers of α1-antitrypsin leads to
gross expansion of ER cisternae and impairment of ER luminal mobility. This hinders the
organelle’s capacity to deal with otherwise minor perturbations of protein folding and thus
leads to enhanced sensitivity to ER stress. Our findings provide one of several potential
mechanisms for the toxicity associated with ER overload in α1-antitrypsin deficiency related
liver disease.
Material and Methods
Plasmid constructs
cDNA for human wildtype α1-antitrypsin and two polymeric mutants (E342K and H334D)
were subcloned into the pTRE2hyg vector (Clontech) for the generation of stable CHO-K1
Tet-On α1-antitrypsin cell lines. The NHK truncated α1-antitrypsin variant (L318fsX17) was
generated with the QuickChangeTM Site-Directed Mutagenesis kit (Stratagene) using
wildtype α1-antitrypsin as the template and then subcloned into the pTRE2hyg plasmid.
Generation and characterization of stable cell lines expressing α1-antitrypsin
The CHO-K1 cell line was purchased from Clontech and stable cell lines were generated by
following the manufacturer’s instructions. The cells were maintained in DMEM
supplemented with 10% v/v Tet-FBS, 1% w/v non-essential amino acids, 1% w/v penicillin/
streptomycin, 200μg/ml Geneticin, and 500μg/ml Hygromycin B (both selective antibiotics
from Invitrogen) at 37°C and 5% v/v CO2. α1-Antitrypsin was typically induced with 1μg/
ml doxycycline for 48h. Whole cell lysates, SDS and non-denaturing polyacrylamide gel
electrophoresis (PAGE) followed by immunoblotting, ELISA analysis and metabolic
labelling were performed as detailed previously4,10 (see Supporting Materials and Methods).
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Immunofluorescence, electron microscopy and immunocytochemistry
Immuno- and electron microscopy of CHO-K1 cells and immunocytochemistry of paraffin
tissue slides from human subjects were undertaken as described in the Supporting Materials
and Methods.
Photobleaching analysis in live cells
CHO-K1 Tet-On cells were transiently transfected with an ER-RFP plasmid11 or a CytERM
msfGFP membrane reporter12. Live cells were imaged on a 37°C environmental controlled
stage of a confocal microscope system (Duoscan; Carl Zeiss Inc.) with a 63x/1.4NA oil
objective and a 40 mW 561nm diode laser with a 565nm bandpass filter. For FRAP/FLIP
experiments, a small region of interest was photobleached at full laser power in the 561 line
and fluorescence recovery or loss was monitored over 0.2s time intervals. Diffusion (Deff)
measurements were calculated as described previously13. Fluorescence loss curves were
obtained by transforming the fluorescence intensities into a percentage scale in which the
first bleach time point represents 100% of fluorescence intensity. Statistical significance was
assessed using Student’s t test.
Detection of the UPR markers
Immunoblots for three main ER luminal chaperone proteins (GRP94, BiP/GRP78, PDI), the
ATF6-reporter luciferase assay and the RT-PCR XBP1 splicing assay were performed as
described previously10.
Results
Conditional expression of α1-antitrypsin
Stable CHO-K1 cell lines were developed using the Tetracycline-On (Tet-On) inducible
system that enables tight regulation of α1-antitrypsin expression. Four clonal cell lines were
generated to express four single variants of α1-antitrypsin: the wildtype human α1-
antitrypsin (M); the polymeric Z [E342K] mutant; the polymeric King’s [H334D] mutant
(both form ordered polymers in the ER of hepatocytes in association with liver disease3,4);
and a NHK truncated variant that does not fold properly, preventing the formation of
ordered polymers, and instead activates the UPR7. Expression of each variant was readily
detected on treating cells with doxycycline (Figs. 1 and S1A–E). Cells expressing M α1-
antitrypsin showed lower intracellular signal compared to medium, consistent with its
efficient secretion. Non-denaturing PAGE and ELISA assays identified intracellular
polymers for only Z and H334D α1-antitrypsin. No ELISA signal was detected for the NHK
variant, suggesting that the 9C5 epitope that is present in monomeric and polymeric forms of
α1-antitrypsin, was removed by the deletion of the C-terminal 61 amino acids. Protein
trafficking rate was assayed by metabolic labeling followed by immunoprecipitation (Fig.
1C). Wildtype α1-antitrypsin was almost completely secreted, compared with Z and H334D
α1-antitrypsin, which were largely retained as polymers. In contrast, NHK α1-antitrypsin
failed to reach the culture medium despite being cleared from the cell lysates at 4h,
consistent with its degradation by ER associated degradation (ERAD)7.
Accumulation of α1-antitrypsin polymers causes disruption of the ER
Immunofluorescence confocal microscopy revealed that both Z and H334D α1-antitrypsin
co-localised with the ER marker BiP, although in many cells the ER structure was distorted
from its reticular morphology into a punctate pattern (Fig. 2A). No gross morphological
changes were observed in cells expressing either M or NHK α1-antitrypsin. Of note, only M
α1-antitrypsin co-localised with the Golgi marker p115, indicating efficient exit from the ER
(Fig. 2A). Electron microscopy was used to visualise cells expressing wildtype and mutant
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α1-antitrypsin. The ultrastructure in cells expressing M α1-antitrypsin was normal (Fig. 2B;
a–b) when they were compared with mock-transfected cells (Fig. 2B; i–k). The inclusions in
cells expressing either Z or H334D α1-antitrypsin were associated with the replacement of
normal tubular and lamellar ER by electron-dense vesiculated structures (Fig. 2B; c–f). In
contrast, expression of the NHK variant induced a markedly different phenotype with
electron lucent dilatation and expansion of the ER throughout the cell (Fig. 2B; g–h). In
order to elucidate whether the alterations observed could be due to a massive overexpression
of α1-antitrypsin in our model, we also assessed the distribution and signal of total α1-
antitrypsin in paraffin-embedded liver sections from a PI*ZZ α1-antitrypsin homozygote
and control human liver by immunocytochemistry (Fig. 2C). The PI*ZZ homozygote human
liver demonstrated levels of polymer accumulation at least as dramatic as that seen in
cultured cells, suggesting that the CHO-K1 Tet-On cells represent a valid model of the
accumulation of α1-antitrypsin polymers within the ER. Taken together, these data show
that the accumulation of ordered polymers within the ER leads to gross changes in the
organelle’s morphology and importantly that these changes differ markedly from those
induced by the NHK mutant that causes classical ER stress.
Polymeric mutants of α1-antitrypsin impair ER protein mobility in live cells
The impact of polymer formation on the ER luminal environment was determined by
monitoring changes in the mobility of the ER-RFP fluorescence marker in live cells. ER-
localised RFP is a protein (27kDa and 2.3 nm hydrodynamic radius) with no known
interacting partners that can rapidly sample the entire ER lumen, reporting on both
crowdedness and interconnectivity11. The ER-RFP distribution revealed two distinct ER
architectures in cells expressing α1-antitrypsin variants. Each cell line displayed a typical
ER reticular network in the absence of doxycycline, as did cells expressing M and NHK α1-
antitrypsin when treated with doxycycline (Fig. S2). In contrast, approximately 30–40% of
cells expressing Z and H334D α1-antitrypsin developed a characteristic vesiculated
architecture when treated with doxycycline (Fig. S2), as detected by staining for either α1-
antitrypsin or BiP (Fig. 2A). Within the same clonal cell lines there remained a proportion of
cells expressing Z and H334D α1-antitrypsin that retained the normal reticular pattern of
ER, suggesting that formation of inclusion bodies is a stochastic phenomenon (Fig. S3).
We then assessed the ER lumen continuity by fluorescence loss in photobleaching (FLIP)14,
in which a small region of the cell ER-RFP fluorescence was repeatedly photobleached. If
the protein is mobile within a continuous compartment, the total fluorescence within this
compartment will be depleted. Over time, ER-RFP fluorescence in the whole cell was
steadily and uniformly lost in cells displaying a tubular ER network, whereas fluorescence
depletion was substantially slower in cells containing Z α1-antitrypsin polymer (Fig. 3A and
Movies S1 and S2). This did not reflect an effect of transfected ER-RFP expression levels,
since normalised plots showed that the remaining whole cell fluorescence intensity after 200
s was 23.5% and 61.1% for cells retaining a tubular ER network or a polymer-filled ER,
respectively (Fig. 3A). Similar results were obtained for cells expressing H334D α1-
antitrypsin (Fig. 3B). Thus, the presence of vesiculated structures is associated with marked
loss of intra-ER luminal communication (slower ER-RFP mobility between inclusions) that
is likely to adversely increase the heterogeneity of the ER luminal environment.
FRAP analysis was used to quantify the change in mobility of the ER-RFP reporter (Fig.
4A). This provides information on local rates of protein diffusion, Deff (μm2/s) by bleaching
a small defined region of a single cell. Deff is affected by local viscosity, size of the reporter
protein and its protein-protein interactions15 and is inversely proportional to crowdedness of
the environment. Moreover, small changes in Deff are likely to be biologically significant11.
No significant differences in the mobility of ER-RFP were detected in the different cell lines
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in the absence of α1-antitrypsin expression (Fig. 4B). ER-RFP Deff values in cells expressing
NHK and M α1-antitrypsin were identical (2.84±0.30 vs. 2.83±0.55 μm2/s). However, cells
containing polymers of either Z or H334D α1-antitrypsin exhibited significantly lower ER-
RFP Deff values compared with M α1-antitrypsin (0.34±0.05 and 0.22±0.03 μm2/s
respectively; Figs. 4A and B, and Movies S2 and S3).
The striking effect of polymers on the ER-RFP diffusion within the lumen of the ER,
prompted an assessment of their effect on the diffusion of an ER transmembrane reporter.
We used the CytERM msfGFP plasmid, which encodes a signal domain required to anchor
the fluorescent protein into the ER membrane with the sfGFP exposed to the cytoplasm12.
There is no luminal domain and consequently the luminal content has no effect on
membrane protein diffusion. There were no significant differences in CytERM msfGFP Deff
values in cells containing polymers of H334D α1-antitrypsin compared to cells in which
expression was not induced (0.35±0.04 vs. 0.40±0.02 μm2/s) (Fig. 4C).
Taken together, these data demonstrate that inclusions of α1-antitrypsin polymers have a
remarkable effect on the ER environment reducing luminal protein diffusion. However
protein mobility within ER membranes is unaffected, indicating that cisternae connectivity
is not disrupted.
Increased susceptibility to ER stress in polymer expressing cells
Previous work has shown that the ER accumulation of ordered polymers of mutant α1-
antitrypsin and another member of the same protein family, neuroserpin, fail to activate the
UPR16–19. However, a recent report has suggested that Z α1-antitrypsin polymer
accumulation triggers UPR activation in peripheral blood monocytes20. We hypothesised
that the alteration of the ER luminal environment might destabilise ER homeostasis
sufficiently to sensitise the cell to a second insult and so trigger activation of the UPR. The
activation of multiple reporters of UPR signalling was monitored following treatment with
tunicamycin, an inhibitor of N-linked glycosylation. Immunoblot analysis for three ER
luminal chaperones (BiP/GRP78, GRP94 and PDI) confirmed that ordered polymers of α1-
antitrypsin alone failed to activate the UPR (Fig. 5A; lanes 1–3). In contrast and as expected,
synthesis of the truncated NHK α1-antitrypsin led to robust activation of the UPR (Fig. 5A;
lane 4). Remarkably, both polymerogenic α1-antitrypsin variants showed a hypersensitive
response in UPR activation following treatment with low concentrations of tunicamycin (5–
25 ng/ml) when compared to the wildtype protein (Fig. 5A).
A more quantitative reporter assay was used to assess the activation of the ATF6 branch of
the UPR. Only cells expressing NHK α1-antitrypsin showed measureable activation of
ATF6 under non-stressed conditions (Fig. 5B). However cells expressing polymeric variants
were more susceptible to activation of ATF6 on treatment with moderate concentrations of
tunicamycin (60–300 ng/ml). A similar response was seen when cells were treated with low
concentrations of glucose (10-0.2 mM), which represents a more physiological ER stress
(Fig. 5C).
IRE1 activation was assessed by the splicing of XBP1 mRNA. None of the cell lines showed
spliced XBP1 mRNA under basal conditions. However, tunicamycin (300 ng/ml) efficiently
triggered IRE1 in all cell lines as reported by the appearance of a smaller spliced XBP1
mRNA band (Fig. 5D). The failure to detect splicing of XBP1 mRNA in cells induced to
express the NHK variant in the absence of tunicamycin reflects the transitory nature of IRE1
activation21. Following the induction of ER chaperones, which occurs rapidly on expressing
this truncated mutant, ER stress is alleviated and IRE1 returns to its inactive state. Indeed,
the elevated level of ER chaperones in NHK-expressing cells served to protect them from
subsequent ER stress, as evidenced by the blunted response of XBP1 splicing seen in these
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cells (Fig. 5D). In contrast, on treatment with tunicamycin, M, Z- and H334D-expressing
cells showed rapid splicing of XBP1 mRNA. These data indicate that the presence of
polymers does not affect the intrinsic activity of IRE1. They do, however, impair the cell’s
ability to restore ER homeostasis, since higher levels of spliced XBP1 mRNA persisted after
16h treatment with tunicamycin in cells expressing both Z and H334D α1-antitrypsin
compared to the wildtype protein.
It is possible that differences in the sensitivity to tunicamycin might be responsible for the
enhanced UPR activation in cells that express polymers of α1-antitrypsin. However this was
not the case as treatment with tunicamycin resulted in equal levels of a slower migrating
glycosylated form of α1-antitrypsin and a faster migrating non-glycosylated form in each
α1-antitrypsin expressing cell line (Fig. S4).
Discussion
It is well recognised that point mutations of α1-antitrypsin form ordered polymers that are
retained as inclusions within the ER, resulting in ER dysfunction and liver disease8. These
inclusions form in the face of effective disposal of misfolded monomer and polymers by
ERAD18,22 and autophagy23. One of the cellular consequence of the accumulation of these
ordered polymers is the ER overload response (EOR), which results in the release of ER
calcium and the activation of NF-κB, a central mediator of inflammation19,24. This pathway
is distinct from the canonical UPR, which is triggered by the accumulation of misfolded
protein and results in the inhibition of protein synthesis, induction of ER chaperones and ER
stress25. The ER overload response and UPR pathways often occur together but mutants of
α1-antitrypsin provide ideal tools to probe these pathways as the polymer forming mutants
activate only the EOR16–19, whilst truncated mutants activate only the UPR7.
We have used two polymeric mutants of α1-antitrypsin (E342K and H334D) to determine
the mechanism by which ER overload can impact on the organization of the ER
environment and the cell’s susceptibility to ER stress. Our data reveal that polymers of α1-
antitrypsin accumulate in spherical, apparently vesiculated ER, concomitantly with loss of
the normal branching tubule network. Similar ER vesiculation has been reported to be
associated with other cellular stresses, including mechanical injury and elevated cytosolic
calcium concentration, although the physiological relevance of this remains unclear26,27.
Live-cell imaging revealed that accumulation of polymers in vesiculated ER leads to a
marked and specific impairment of luminal protein mobility due to an increased ER
heterogeneity, which might reflect a change in either the luminal viscosity and/or in the
tortuosity for ER-RFP diffusion within and between spherical inclusions. Interestingly, the
truncated NHK mutant that causes classical ER stress (UPR) and is efficiently degraded by
the proteasome showed a different ultrastructural change characterised by gross expansion
of ER cisternae. This had no effect on luminal protein mobility. Current technology limits
the area of photobleaching to slightly larger than the size of an inclusion. However, since
effects of photobleaching were examined by FLIP throughout the cell, we are confident in
these findings. It will be valuable, when the technology has improved sufficiently, to revisit
the diffusion between individual inclusions.
In agreement with previous studies16–19, we report that cells expressing polymers of either Z
or H334D α1-antitrypsin do not show constitutive activation of the UPR. However these
cells do exhibit a hypersensitivity to both pharmacological and physiological ER stressors.
To date, most studies that have attempted to detect ER stress in cells expressing mutant α1-
antitrypsin have made use of methods such as the up-regulation of ER chaperones. Although
providing important insights, such approaches have been unable to address how ER overload
with polymers of α1-antitrypsin might impact on the molecular organization of the ER
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organelle. Our observation that enhanced sensitivity to ER stress following the expression of
polymerogenic α1-antitrypsin mutants correlates with the presence of marked changes in the
biophysical features of the ER suggests a mechanism for this phenomenon (Fig. 6).
Chaperones can readily diffuse to sites of protein misfolding in cells possessing a reticular
and highly interconnected ER. In contrast, in cells experiencing ER overload, a comparable
level of misfolded client protein cannot diffuse freely, decreasing their accessibly to quality
control proteins required for folding and transport. Therefore, we propose a model in which
decreased mobility or availability of ER chaperones due to changes in the diffusive features
or/and obstruction caused by protein overload, sensitises the cell to subsequent activation of
the UPR by a second hit that further increases the unfolded secretory protein burden. Our
findings are directly relevant to the liver disease associated with polymerogenic mutants of
α1-antitrypsin. However, although polymer accumulation involves a gain-of-function
associated with liver dysfunction, epidemiological studies have shown that only 10% of
patients with α1-antitrypsin deficiency develop clinically apparent liver disease28. It appears
that additional, incompletely understood genetic and environmental factors contribute to this
heterogeneity in hepatic phenotype29,30. Our results suggest that polymer accumulation
increases the vulnerability of the cell to a ‘second hit’ that ultimately initiates liver disease in
individuals with α1-antitrypsin deficiency. Moreover, the mechanism proposed is likely to
be relevant to other serpinopathies, such as the neuronal toxicity associated with polymers of
neuroserpin in the dementia FENIB31.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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α1AT α1-antitrypsin
Deff Effective diffusion coefficient
Dox Doxycycline
EOR Endoplasmic overload response
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FRAP Fluorescence recovery after photobleaching
Tm Tunicamycin
UPR Unfolded protein response
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Fig. 1. Characterisation of CHO-K1 Tet-On cell lines expressing different variants of α1-
antitrypsin (α1AT): wildtype (M), Z (E342K), HD (H334D) and the truncated Null Hong Kong
(NHK) variant
A) Cell lysates and medium were collected after induction of α1-antitrypsin with 1μg/ml
doxycycline (dox) for 48h and analysed by 10% w/v SDS and non-denaturing PAGE
followed by immunoblot for α1-antitrypsin. B) Percentage of secreted total α1-antitrypsin
and quantification of intracellular polymers for M, Z and HD α1-antitrypsin were quantified
by sandwich ELISA using the 9C5 (left panel) or 2C1 (right panel) monoclonal antibodies,
that recognise all forms of α1-antitrypsin or only polymers, respectively. The graphs show
mean±SEM (n=4). C) CHO-K1 Tet-On cells expressing M, Z, HD and NHK α1-antitrypsin
were pulse-labeled with 35S-Met/Cys for 15min and chased for the times indicated (0 – 4h).
α1-Antitrypsin from cell lysates and medium was immunoprecipitated with a polyclonal
antibody (total) or the 2C1 monoclonal antibody (polymers) and then samples were resolved
by 10% w/v SDS PAGE and detected by autoradiography. Gels are representative of three
independent experiments.
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Fig. 2. Intracellular accumulation of α1-antitrypsin polymers in inclusion bodies disrupts ER
structure
A) Representative fluorescence images of Tet-On CHO-K1 cells induced to express M, Z,
HD and NHK α1-antitrypsin with dox for 48h, fixed and co-immunostained with an α1-
antitrypsin polyclonal antibody and either an ER protein marker (BiP) or a Golgi protein
marker (p115). White arrows in the merge panels show a punctate pattern of co-localised
polymerogenic forms of α1-antitrypsin (Z and HD) with the ER marker (left panel) or
wildtype α1-antitrypsin co-localised with the Golgi marker (right panel). B) Electron
microscopy analysis for ER structure in Tet-On CHO-K1 cells expressing α1-antitrypsin
variants. Upper panels represent whole cells, with higher power images shown in lower
panels. Black arrows indicate the ER cisterns. Inclusion bodies were only identified in
micrographs of the polymerogenic mutants (Z and HD α1-antitrypsin). C) Immunostaining
of paraffin-embedded liver sections from a PI*ZZ α1-antitrypsin individual and a normal
control liver with a polyclonal antibody to total α1-antitrypsin (white arrow).
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Fig. 3. Luminal α1-antitrypsin inclusion bodies impair protein mobility within the ER lumen
A) FLIP analysis of Z α1-antitrypsin cells expressing ER-RFP within both a tubular ER
network cell (without dox) and an α1-antitrypsin polymer-filled ER (with dox for 48h). FLIP
normalised plots setting the pre-bleach intensity as 100%. B) FLIP of H334D α1-antitrypsin
cells expressing ER-RFP within both a tubular ER network cell and an α1-antitrypsin
polymer-filled ER from the same sample after treatment with dox for 48h. Normalised plots
from FLIP analysis as described in 3A. Fluorescence loss was specific, as adjacent cells
remained fluorescent (white arrow). White boxes represent the region subjected to
photobleaching.
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Fig. 4. Polymers of α1-antitrypsin modify the ER luminal environment decreasing ER protein
mobility
A) Left: FRAP series of Tet-On CHO-K1 cells induced to express M, Z, HD and NHK α1-
antitrypsin with dox for 48h and transiently co-transfected with ER-RFP. Cells expressing
either Z or HD α1-antitrypsin show a vesiculated pattern in which the fluorescence recovery
was significantly reduced. All images were captured immediately before (pre-bleach),
immediately after (post-bleach) and at times after photobleaching in the white box. Scale
bar: 10μm. Right: Deff values from FRAP analysis in individual cells. B) Mean values±SEM
for each condition and variant in 4A. C) Upper panel: Deff values from FRAP analysis in
individual Tet-On HD CHO-K1 cells treated with or without dox for 48h and transiently co-
transfected with both ER-RFP and CytERM msfGFP membrane reporter. Lower panel:
Mean±SEM for each condition and construct. *** p<0.0001 in a two-tailed Student t test.
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Fig. 5. Differential activation of three UPR sensors in polymeric forms of α1-antitrypsin reveals
an increased sensitivity to UPR following a second hit
A) Immunoblot of whole cells lysates from CHO-K1 Tet-On cells induced with dox for 48h
and treated with the indicated doses of tunicamycin (Tm) for 16h. Grouping of separated
lanes within the same gel was performed and indicated by dividing white lines. Histogram
representation of four independent replicates of experiment 5A showing fold increase of
GRP94, BiP/GRP78 or PDI normalised to loading control and then to wildtype variant for
each concentration of tunicamycin (mean±SEM). B and C) ATF6 activation during
induction of ER stress. α1-Antitrypsin expression was induced with dox for 48h. Twenty-
four hours prior to lysis, the cells were co-transfected for 6h with a p5xATF6-Luc encoding
firefly luciferase under the control of a UPR response element and with pRL-TK Renilla
luciferase as a normalization control, and then treated with the indicated doses of
tunicamycin (B) or glucose (C) for 16h. The graphs show firefly luciferase normalised to
Renilla luciferase, as mean±SEM (n=3). C) XBP1 processing during ER stress induction.
Cells were induced with dox for 48h and subjected to a time course of tunicamycin
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treatment (300 ng/mL). RT-PCR was used to amplify XBP1 mRNA and PCR products were
resolved by 2% w/v agarose gel electrophoresis. The ratio of spliced/unspliced XBP1 mRNA
for each α1-antitrypsin variant after 16h tunicamycin is represented graphically as mean
±SEM (n=3). *p<0.05, **p<0.01, or ***p<0.001 according to ANOVA test followed by a
Bonferroni post hoc test.
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Fig. 6. Model for the enhanced sensitivity to ER stress seen in cells experiencing ER overload
An insult resulting in misfolded client protein is effectively buffered by chaperone diffusion
in healthy cells. This prevents ER stress (“resolved”). In contrast, in cells that accumulate
polymerised protein, the global ER environment is affected that impairs chaperone access to
misfolded proteins thereby increasing the cell’s propensity to experience ER stress
(“unresolved”). Yellow represents a resolved ER stress, while orange corresponds to an
unresolved ER response to ER overload.
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